Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Dauch Corporation enters the final stretch of Q3 reporting season with a contradictory setup: short sellers remain heavily dug in at 15.3% of the free float, yet the stock just posted a 10% weekly gain to $5.85, its strongest week in months even as the one-month picture shows a 16% loss.
The short positioning tells a story of entrenchment rather than aggression. Short interest has barely moved, edging up just 0.4% on the week to roughly 18.2 million shares. That follows a sharper step-down in mid-September, when positions dropped from around 20.5 million shares to the current range in a matter of days, a reduction that has since stabilised. The borrow market gives shorts no reason to rush: cost to borrow is running at just 0.51%, down about 7% on the week, and availability is extraordinarily loose at over 3,000%, meaning there are more than 30 shares available to lend for every one already borrowed. That is among the most relaxed lending conditions in the current 30-day window. With borrow this cheap and plentiful, there is no mechanical squeeze pressure on the short book.
Options positioning leans bullish. The put/call ratio is 0.21, marginally below its 20-day average and well beneath the 52-week high of 0.40 hit in late August. Call demand has been dominant for several weeks now. The z-score of -0.30 is unremarkable, but the sustained low-PCR trend is consistent with the view that buyers, not hedgers, have controlled the options flow. The ORTEX short score of 49.0 sits in neutral territory and has been range-bound all month, down slightly from a brief spike above 51 on September 23.
The Street picture for DCH is harder to assess with confidence. Valuation multiples are uninspiring: the stock trades at 5.2 times trailing earnings and just 0.87 times book, the price-to-book having fallen 0.17 over the past month even as the PE ratio has compressed by 1.3 turns. EV/EBITDA of 3.3x is low in absolute terms for an automotive supplier, which may reflect genuine distress risk or simply deep-value territory. Factor scores are mixed: the EPS surprise rank is in the 9th percentile, meaning DCH consistently misses estimates, and the sector score is exactly mid-table at 50. The days-to-cover rank is more supportive at 63. No analyst data with sufficient recency was available to include.
The most interesting institutional angle is Greenlight Capital, controlled by David Einhorn's DME Advisors GP, which filed a Schedule 13G in August disclosing a 5.2% stake of 12.4 million shares. Greenlight has historically taken positions in deeply discounted situations, and at sub-book pricing DCH fits that profile. BlackRock holds 16% of shares and added roughly 900,000 shares in the most recent reporting period. State Street and Fidelity also added. Against that, Goldman Sachs trimmed its position by over 3 million shares through June. As is standard with 13D/G filings, stakes are as-last-disclosed around the 5% threshold and positions may have changed without a further filing.
The August earnings print is worth noting as context. The stock jumped 17% on the day and held most of that gain over the following week. Next earnings fall on 13 November, and with the one-month down 16% trend now colliding with this week's sharp bounce, that print will clarify whether the recovery has legs or whether the short book at 15.3% of float is reading the setup correctly.
See the live data behind this article on ORTEX.
Open DCH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
